Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.

AIMS Comparative studies on the longevity of implantable cardioverter-defibrillators (ICDs) among different manufacturers have never been reported. Longevity of ICD devices implanted from 1 January 2000 to 31 December 2002 was prospectively investigated according to their type and manufacturer. METHODS AND RESULTS Longevity of single-chamber (SC), double-chamber (DC), and biventricular (CRT-D) ICDs from Medtronic (MDT), Guidant (GDT), and St Jude Medical (SJM) was measured in all the patients who required device replacement. The observation follow-up ended on 31 December 2007; patients who died prematurely or were transplanted before battery exhaustion were excluded from the analysis. Factors associated with longevity (number of delivered shocks, pacing activity) were researched. One hundred and fifty-three patients received an ICD in the abovementioned period. Six underwent heart transplantation, and 23 died before device replacement; 80 had an SC device, 59 had DC device, and 14 had CRT-D device. Longevity of MDT was superior to GDT and SJM, replacement rates being, respectively, 42%, 95.3%, and 97.2%. Only MDT manufacturers and SC type were associated with greater ICD longevity. Longevity had an impact on the cost/month of treatment of replaced ICDs. CONCLUSION Battery longevity is significantly different among manufacturers. ICD cost is strictly dependent on device longevity, whereas device up-front cost is of limited clinical meaning. Appropriate assessment of cost-effectiveness should be based on ICD longevity in the real-life scenario.

[1]  G. Boriani,et al.  Evolution of pacing for bradycardia: Autocapture , 2007 .

[2]  M. Biffi,et al.  Clinical Evaluation of Two Different Evoked Response Sensing Methods for Automatic Capture Detection in the Left Ventricle , 2007, Pacing and clinical electrophysiology : PACE.

[3]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[4]  G. Kay,et al.  Pacing Threshold Increase in Nonthoracotomy Implantable Defibrillator Leads: Implications for Battery Longevity and Margin of Safety , 1997, Journal of Interventional Cardiac Electrophysiology.

[5]  R. Califf,et al.  Clinical and Economic Implications of the Multicenter Automatic Defibrillator Implantation Trial-II , 2005, Annals of Internal Medicine.

[6]  R. Hauer,et al.  Can implantable cardioverter-defibrillator therapy reduce healthcare costs? , 1996, The American journal of cardiology.

[7]  Variability in Implantable Cardioverter Defibrillator Pulse Generator Longevity Between Manufacturers , 2003, Pacing and clinical electrophysiology : PACE.

[8]  A. Hunt.  The patient's viewpoint. , 1992, Disease markers.

[9]  Paul J. Wang,et al.  Use of the AutoCapture Pacing System with Implantable Defibrillator Leads , 2003, Pacing and clinical electrophysiology : PACE.

[10]  Paul A. Belk,et al.  Randomized pilot study of a new atrial-based minimal ventricular pacing mode in dual-chamber implantable cardioverter-defibrillators. , 2004, Heart rhythm.

[11]  V Parsonnet,et al.  Feasibility and Initial Results of an Internet‐Based Pacemaker and ICD Pulse Generator and Lead Registry , 2001, Pacing and clinical electrophysiology : PACE.

[12]  J. Camm,et al.  The cost of implantable defibrillators: perceptions and reality. , 2007, European heart journal.

[13]  A. Tsiatis,et al.  Cost-Effectiveness of Defibrillator Therapy or Amiodarone in Chronic Stable Heart Failure: Results From the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) , 2006, Circulation.

[14]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[15]  M. Sweeney,et al.  Appropriate and Inappropriate Ventricular Therapies, Quality of Life, and Mortality Among Primary and Secondary Prevention Implantable Cardioverter Defibrillator Patients: Results From the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) Trial , 2005, Circulation.

[16]  J. Morgan.  Cost‐Effectiveness of Implantable Cardioverter Defibrillator Therapy , 2002, Journal of cardiovascular electrophysiology.

[17]  G. Boriani,et al.  Atrial Threshold Variability: Implications for Automatic Atrial Stimulation Algorithms , 2007, Pacing and clinical electrophysiology : PACE.

[18]  Craig L. Schmidt,et al.  Hybrid cathode lithium batteries for implantable medical applications , 2006 .

[19]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[20]  Craig L. Schmidt,et al.  Evolution of power sources for implantable cardioverter defibrillators , 2001 .

[21]  M. Irwin,et al.  Pacemaker Longevity: Are We Getting What We Are Promised? , 2006, Pacing and clinical electrophysiology : PACE.

[22]  R. Hauser,et al.  The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. , 2005, Journal of the American College of Cardiology.

[23]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[24]  A. Fitzpatrick,et al.  How should we cost ICD therapy? , 2007, International journal of cardiology.

[25]  P. Friedman,et al.  Determination of Pacing Capture in Implantable Defibrillators: Benefit of Evoked Response Detection Using RV Coil to Can Vector , 2000, Pacing and clinical electrophysiology : PACE.

[26]  D. Fitzgerald,et al.  Estimating Defibrillator Longevity: A Need for an Objective Comparison , 1997, Pacing and clinical electrophysiology : PACE.

[27]  Douglas K Owens,et al.  Cost-effectiveness of implantable cardioverter-defibrillators. , 2005, The New England journal of medicine.

[28]  J. Fisher,et al.  Pacemakers and Implantable Cardioverter Defibrillators: , 2004, Pacing and clinical electrophysiology : PACE.

[29]  Paul M. Skarstad,et al.  Battery and capacitor technology for uniform charge time in implantable cardioverter-defibrillators , 2004 .

[30]  G. Crossley,et al.  Automated Left Ventricular Capture Management , 2007, Pacing and clinical electrophysiology : PACE.

[31]  Craig L. Schmidt,et al.  Modeling Li ∕ CF x -SVO Hybrid-Cathode Batteries , 2007 .

[32]  G. Boriani,et al.  Left ventricular pacing by automatic capture verification. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[33]  Zengri J. Wang,et al.  A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. , 2006, Journal of the American College of Cardiology.

[34]  G. Boriani,et al.  Role of ventricular Autocapture function in increasing longevity of DDDR pacemakers: a prospective study. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[35]  A. Krahn,et al.  Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. , 2006, JAMA.

[36]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[37]  D. Cannom,et al.  Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. , 2006, Heart rhythm.